Product Code: IRTNTR20053
About Spine Biologics
The spine biologics market is fragmented due to the presence of several players. The market is quite competitive and to sustain the competition, the vendors are focusing on differentiating their products based on price, quality, regulatory compliance, and innovation. Based on product type the market can be segmented as Bone grafts, BMPs, and BMAC. During 2017, the bone grafts segment accounted for the major share of the spine biologics market. Allograft is the method by which tissue transplant takes place between individuals with a different genotype. It is extensively used in several life-saving procedures such as pain relief, limbs repair, and improvement of the life quality of patients.
Technavio's analysts forecast the global spine biologics market to grow at a CAGR of 4.09% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global spine biologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of spine biologics.
The market is divided into the following segments based on geography:
Technavio's report, Global Spine Biologics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Alphatec Spine
- Globus Medical
- Medtronic
- NuVasive
Other Prominent Vendors
- AlloSource
- AMENDIA
- ChoiceSpine
- DePuy Synthes
- Exactech
- Harvest Technologies
Market driver
- Growing geriatric population
- For a full, detailed list, view our report
Market trend
- Increasing adoption of minimally invasive surgeries
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 06: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 08: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Global bone grafts market
- Global BMPs market
- Global BMAC market
- Global others market
- Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Spine biologics market in Americas
- Spine biologics market in EMEA
- Spine biologics market in APAC
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Growing strategic alliances
- Increasing cases of lumbar fusion
- Increasing adoption of minimally invasive surgery
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Alphatec Spine
- Globus Medical
- Medtronic
- NuVasive
PART 15: APPENDIX
List of Exhibits
- Exhibit 01: Parent market
- Exhibit 02: Global spine biologics market 2017
- Exhibit 03: Market characteristics
- Exhibit 04: Market segments
- Exhibit 05: Market definition: Inclusions and exclusions checklist
- Exhibit 06: Market size 2017
- Exhibit 07: Validation techniques employed for market sizing 2017
- Exhibit 08: Global spine biologics market size and forecast 2017-2022 ($ millions)
- Exhibit 09: Global spine biologics market: Year-over-year growth 2018-2022 (%)
- Exhibit 10: Five forces analysis 2017
- Exhibit 11: Five forces analysis 2022
- Exhibit 12: Bargaining power of buyers
- Exhibit 13: Bargaining power of suppliers
- Exhibit 14: Threat of new entrants
- Exhibit 15: Threat of substitutes
- Exhibit 16: Threat of rivalry
- Exhibit 17: Market condition - Five forces 2017
- Exhibit 18: Spine biologics product market share 2017-2022 (%)
- Exhibit 19: Comparison by product
- Exhibit 20: Global bone grafts market 2017-2022 ($ millions)
- Exhibit 21: Global bone grafts market: YOY growth 2018-2022 (%)
- Exhibit 22: Global BMPs market 2017-2022 ($ millions)
- Exhibit 23: Global BMPs market: YoY growth 2018-2022 (%)
- Exhibit 24: Global BMAC market 2017-2022 ($ millions)
- Exhibit 25: Global BMAC market: YoY growth 2018-2022 (%)
- Exhibit 26: Global others market 2017-2022 ($ millions)
- Exhibit 27: Global others market: YoY growth 2018-2022 (%)
- Exhibit 28: Market opportunity by product
- Exhibit 29: Customer landscape
- Exhibit 30: Global spine biologics market share by geography 2017-2022 (%)
- Exhibit 31: Regional comparison
- Exhibit 32: Spine biologics market in Americas 2017-2022 ($ millions)
- Exhibit 33: Spine biologics market in Americas: YoY growth 2018-2022 (%)
- Exhibit 34: Top three countries in Americas
- Exhibit 35: Spine biologics market in EMEA 2017-2022 ($ millions)
- Exhibit 36: Spine biologics market in EMEA: YoY growth 2018-2022 (%)
- Exhibit 37: Top three countries in EMEA
- Exhibit 38: Spine biologics market in APAC 2017-2022 ($ millions)
- Exhibit 39: Spine biologics market in APAC: YoY growth 2018-2022 (%)
- Exhibit 40: Top three countries in APAC
- Exhibit 41: Market opportunity
- Exhibit 42: World population by age group 2015-2050 (in millions)
- Exhibit 43: Benefits of minimally invasive technique
- Exhibit 44: Vendor landscape
- Exhibit 45: Landscape disruption
- Exhibit 46: Vendors covered
- Exhibit 47: Vendor classification
- Exhibit 48: Market positioning of vendors
- Exhibit 49: Alphatec Spine: Overview
- Exhibit 50: Alphatec Spine: Business segments
- Exhibit 51: Alphatec Spine: Organizational developments
- Exhibit 52: Alphatec Spine: Geographic focus
- Exhibit 53: Alphatec Spine: Segment focus
- Exhibit 54: Alphatec Spine: Key offerings
- Exhibit 55: Alphatec Spine: Key customers
- Exhibit 56: Globus Medical: Overview
- Exhibit 57: Globus Medical: Business segments
- Exhibit 58: Globus Medical: Organizational developments
- Exhibit 59: Globus Medical: Geographic focus
- Exhibit 60: Globus Medical: Segment focus
- Exhibit 61: Globus Medical Key offerings
- Exhibit 62: Globus Medical: Key customers
- Exhibit 63: Medtronic: Overview
- Exhibit 64: Medtronic: Business segments
- Exhibit 65: Medtronic: Organizational developments
- Exhibit 66: Medtronic: Geographic focus
- Exhibit 67: Medtronic: Segment focus
- Exhibit 68: Medtronic: Key offerings
- Exhibit 69: Medtronic: Key customers
- Exhibit 70: NuVasive: Overview
- Exhibit 71: NuVasive: Business segments
- Exhibit 72: NuVasive: Organizational developments
- Exhibit 73: NuVasive: Geographic focus
- Exhibit 74: NuVasive: Segment focus
- Exhibit 75: NuVasive: Key offerings
- Exhibit 76: NuVasive: Key customers
